Recombinant cytokines have been used as therapeutics for cancers, autoimmune diseases, and infectious diseases, but their application in wound healing and tissue regeneration remains relatively underdeveloped. Short half-lives, narrow therapeutic windows, and a myriad of adverse effects due to pleiotropy and redundancy...
Isabella Horton, Katharina Maisel, K. Sadtler· Biomaterials· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.